Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.
Also called NCT02244879
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 192 participants
- Registry
-
NCT02244879
-
- Other papers using this trial's data
- Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial
- Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT02244879. Randomized; triple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Inflammation
- Condition
- Insulin Resistance
- Condition
- Other Disorders of Bone Density and Structure
- Intervention (Dietary supplement)
- resveratrol
- Lead sponsor
- University of Turin, Italy
- Collaborator
- Ministry of Health, Italy
Record details
- Record id
cardio:ct-nct02244879- Content hash
3f13e8818d479e95b8161e4022ebad528e20e63c76305ab2a087f1fe5686c342